美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA203844"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
71209-014-03 71209-014 HUMAN PRESCRIPTION DRUG Rivastigmine Tartrate Rivastigmine Tartrate CAPSULE ORAL 20140211 N/A ANDA ANDA203844 Cadila Pharmaceuticals Limited RIVASTIGMINE TARTRATE 4.5 mg/1 60 CAPSULE in 1 BOTTLE (71209-014-03)
71209-014-10 71209-014 HUMAN PRESCRIPTION DRUG Rivastigmine Tartrate Rivastigmine Tartrate CAPSULE ORAL 20140211 N/A ANDA ANDA203844 Cadila Pharmaceuticals Limited RIVASTIGMINE TARTRATE 4.5 mg/1 500 CAPSULE in 1 BOTTLE (71209-014-10)
71209-015-03 71209-015 HUMAN PRESCRIPTION DRUG Rivastigmine Tartrate Rivastigmine Tartrate CAPSULE ORAL 20140211 N/A ANDA ANDA203844 Cadila Pharmaceuticals Limited RIVASTIGMINE TARTRATE 6 mg/1 60 CAPSULE in 1 BOTTLE (71209-015-03)
71209-015-10 71209-015 HUMAN PRESCRIPTION DRUG Rivastigmine Tartrate Rivastigmine Tartrate CAPSULE ORAL 20140211 N/A ANDA ANDA203844 Cadila Pharmaceuticals Limited RIVASTIGMINE TARTRATE 6 mg/1 500 CAPSULE in 1 BOTTLE (71209-015-10)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase